Comorbidities
|
Claim data1(A)
|
Prescribing information2(B)
|
Claim data ∩ Prescribing information3(A∩B)
| Fraction of additional comorbidities inferred by prescribing information {(A∪B)-A}/(A∪B) |
---|
Peripheral vascular disorders
|
6,707
|
21,858
|
2,452
|
74.3%
|
Psychoses
|
1,719
|
4,614
|
1,420
|
65.0%
|
Chronic pulmonary disease
|
26,038
|
36,129
|
16,517
|
43.0%
|
Congestive heart failure
|
5,423
|
4,159
|
1,419
|
33.6%
|
Deficiency anemia
|
12,518
|
12,949
|
6,927
|
32.5%
|
Depression
|
8,267
|
4,420
|
2,134
|
21.7%
|
Other neurological disorders
|
7,037
|
2,900
|
1,491
|
16.7%
|
Hypothyroidism
|
5,346
|
2,792
|
1,909
|
14.2%
|
Renal failure
|
4,952
|
1,054
|
400
|
11.7%
|
Weight loss
|
7,445
|
556
|
130
|
5.4%
|
AIDS
|
35
|
10
|
8
|
5.4%
|
Cardiac arrhythmia
|
10,310
|
975
|
646
|
3.1%
|
Rheumatoid arthritis/ collagen vascular diseases
|
3,530
|
144
|
73
|
2.0%
|
Liver disease
|
21,051
|
255
|
187
|
0.3%
|
- 1 No. of cases of each Elixhauser comorbidity identified from claim data, 2 No. of cases each Elixhauser comorbidity inferred from drug prescribing information, 3 No. cases of each Elixhauser comorbidity identified (or inferred) both claim data and drug prescribing information.